Stryker Corporation (SYK) Stock Analysis & Investment Frameworks
Stryker Corporation (SYK) stock analysis on Invetso. Review Stryker Corporation’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Stryker Corporation Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Stryker Corporation Key Financial Metrics
- Market Cap: $117.79B
- Revenue: $25.12B
- P/E Ratio: 36.3
- ROE: 16.36%
- ROIC: 9.82%
- Dividend Yield: 1.15%
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Stryker Corporation Investment Frameworks
Invetso analyzes Stryker Corporation (SYK) across the following frameworks:
- Stryker Corporation 10Y Growth Potential
- Stryker Corporation Scenario Analysis
- Stryker Corporation Risks & Opportunities
- Stryker Corporation Economic Moat
- Stryker Corporation Business Model
- Stryker Corporation Management
- Stryker Corporation SWOT Analysis
- Stryker Corporation Porter's 5 Forces
- Stryker Corporation PESTLE Analysis
- Stryker Corporation ESG Analysis